It’s time to find new targets for brain diseases instead of just pursuing old ones
ADOBE
The pharmaceutical industry needs to accept, if not embrace, taking risks on identifying new drug targets for brain diseases.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario